HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

PURPOSE: The role of HHLA2, a new immune checkpoint ligand, is gradually being elucidated in various solid tumours. However, its role in ovarian cancer remains unclear; thus, its expression profile and clinical significance in ovarian cancer must be examined. METHODS: We performed immunohistochemist...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Cell Int
Prif Awduron: Xu, Guocai, Shi, Yuanyuan, Ling, Xiaoting, Wang, Dongyan, Liu, Yunyun, Lu, Huaiwu, Peng, Yongpai, Zhang, Bingzhong
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2021
Pynciau:
Primary Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106145/
https://ncbi.nlm.nih.gov/pubmed/33962626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01930-y
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg